Starpharma boss Jackie Fairley said her licensing deal with AstraZeneca is hard proof the Australian nanotechnology pioneer's drug delivery platform could be worth billions.
On Monday Starpharma announced a deal with AstraZeneca that could be worth more than $US450 million ($650 million) per drug developed using Starpharma's drug delivery technology.
Loading...
Tim Binsted writes on Business specialising in Agriculture, Construction, Manufacturing. Tim is based in our Sydney newsroom. Connect with Tim on Twitter.
